ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
75 hedge funds and large institutions have $27.9M invested in ENZON PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 10 closing their positions.
5% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 21
5% less funds holding
Funds holding: 79 → 75 (-4)
18% less capital invested
Capital invested by funds: $34.2M → $27.9M (-$6.32M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
85% less call options, than puts
Call options by funds: $3K | Put options by funds: $20K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$450K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$366K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
+$348K |
| 4 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$309K |
| 5 |
Renaissance Technologies
New York
|
+$213K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$5.03M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$121K |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$78K |
| 4 |
Goldman Sachs
New York
|
-$55.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$49.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RCM
76
Rotella Capital Management
Bellevue,
Washington
| – | -$16K | -13,701 | Closed |
|
|
SKK
77
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$15K | -13,000 | Closed |
|
78
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$12K | -10,645 | Closed |
|
79
Bank of America
Charlotte,
North Carolina
| – | -$8.81K | -8,528 | -100% |
|
|
YCM
80
Yakira Capital Management
Westport,
Connecticut
| – | -$7K | -5,981 | Closed |
|
81
BNP Paribas Financial Markets
Paris,
France
| – | -$565 | -487 | Closed |
|
ENZN Hedge Fund Activity: Q1 2014 in Review
75 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q1 2014, worth a combined $27.9M — down 18% from $34.2M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ENZN and 7 opened new positions — a net loss of 3 holders — while 21 trimmed existing stakes and 22 added.
The largest buyer was Citadel Advisors, adding an estimated $450K. The largest seller was Baupost Group, exiting entirely with an estimated $5.03M sold.
- 75 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q1 2014, down from 79 in Q4 2013.
- Funds reported $27.9M of ENZON PHARMACEUTICALS INC stock for Q1 2014, down 18% quarter-over-quarter.
- 7 funds opened new ENZON PHARMACEUTICALS INC positions in Q1 2014 and 10 closed out, a net change of -3 holders.
- The largest ENZON PHARMACEUTICALS INC buyer in Q1 2014 was Citadel Advisors, an estimated $450K added.
- The largest ENZON PHARMACEUTICALS INC seller in Q1 2014 was Baupost Group, an estimated $5.03M sold.
Based on aggregated 13F filings for Q1 2014.